Table 1.
Patient preference | Low invasiveness | High invasiveness | |||||
---|---|---|---|---|---|---|---|
| |||||||
Patient goal | Long-term penile health | Short-term erectile function | |||||
| |||||||
PCa treatment status | BNS | UNS | NNS | BNS | UNS | NNS | |
Surgery | Pharmaceutical approach | Daily and PRN full-dose PDE5i | PRN use of full-dose PDE5i | MUSE | ICI | ICI | ICI |
Mechanical approach | VED | VED | VED | VED | VED | VED | |
Radiation | Pharmaceutical approach | Daily and PRN full-dose PDE5i | ICI | ||||
Mechanical approach | VED | VED |
Baseline recommendation for all patients: Regular sexual activity (at least once a week). When applicable, patient’s partners should be included in the treatment plan. BNS: bilateral nerve sparing; ICI: intracavernous injection; NNS: non-nerve sparing; PC: prostate cancer; PDE5i: phosphodiesterase type 5 inhibitors; UNS: unilateral nerve sparing; VED: vacuum erection devices.